IO Biotech, Inc.
IOBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,378 | -$26,217 | -$22,421 | -$31,333 |
| Dep. & Amort. | $230 | $234 | $227 | $219 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,607 | $1,569 | $1,634 |
| Change in WC | -$2,748 | $1,340 | -$2,551 | $5,188 |
| Other Non-Cash | -$7,582 | $3,214 | $105 | $4,667 |
| Operating Cash Flow | -$18,478 | -$19,822 | -$23,071 | -$19,625 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$26 | -$28 | -$11 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$4 | -$26 | -$28 | -$11 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $14,696 | $11,487 | $0 | $0 |
| Stock Issued | $6,574 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $21,270 | $11,487 | $0 | $0 |
| Forex Effect | -$255 | -$594 | $154 | -$518 |
| Net Chg. in Cash | $2,533 | -$8,955 | -$22,945 | -$20,154 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28,131 | $37,354 | $60,299 | $80,453 |
| End Cash | $30,664 | $28,399 | $37,354 | $60,299 |
| Free Cash Flow | -$18,482 | -$19,848 | -$23,099 | -$19,636 |